Skip to main content
TipRanks
Go Ultimate75% OFF

NKGen Biotech Korea Co., Ltd. (182400) Stock Price & Analysis

182400 Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
KRW 172.74B
Enterprise Value
KRW 182.04B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.00
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

182400 FAQ

What is NKGen Biotech Korea Co., Ltd.’s market cap?
NKGen Biotech Korea Co., Ltd.’s market cap is ₩172.74B.
When is NKGen Biotech Korea Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NKGen Biotech Korea Co., Ltd.’s earnings last quarter?
NKGen Biotech Korea Co., Ltd. released its earnings results on Nov 13, 2026. The company reported -$4.373 earnings per share for the quarter.
Is NKGen Biotech Korea Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does NKGen Biotech Korea Co., Ltd. pay dividends?
NKGen Biotech Korea Co., Ltd. does not currently pay dividends.
What is NKGen Biotech Korea Co., Ltd.’s EPS estimate?
NKGen Biotech Korea Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NKGen Biotech Korea Co., Ltd. have?
NKGen Biotech Korea Co., Ltd. has 72,342,430 shares outstanding.
What happened to NKGen Biotech Korea Co., Ltd.’s price movement after its last earnings report?
NKGen Biotech Korea Co., Ltd. reported an EPS of -$4.373 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of NKGen Biotech Korea Co., Ltd.?
Currently, no hedge funds are holding shares in KR:182400
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology